ArticleJournal for immunotherapy of cancer2025

Targeting the extracellular matrix with Tenascin-C-specific CAR T cells extends survival in preclinical models of glioblastoma.

Jana de Sostoa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.